Efficacy and Safety of HGP1910 and HCP1903 in Patients With Primary Hypercholesterolemia

NCT04652349 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

279

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Hypercholesterolemia

Interventions

DRUG: HGP1910
DRUG: HCP1903
DRUG: HGP1909
DRUG: HGP1911

Sponsor

Hanmi Pharmaceutical Company Limited